SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: scope who wrote (10470)7/5/1998 1:16:00 AM
From: John W. Andrews  Read Replies (1) | Respond to of 23519
 
insider sales mean nothing really anyway....especially when many compnesatin pcakges these days are weighted in options and shares....even if the Vivus team was buying..in which some probably are....that would not signal thatthinkgs are great either....

and if Vvus is going down...why have'nt the majority of shares been sold....that argument just doesn't hold water.....

after the 9th....the Q2 loss won;t matter..and the US scripts will take a back seat to internationall growth,.....

Pizzaman



To: scope who wrote (10470)7/5/1998 1:24:00 AM
From: AlienTech  Respond to of 23519
 
>>How come 34 straight insider sales and no purchases when the stock is such a bargain? <<

And were did you get this figure from?
At last count VVUS insiders had excercised options to purchase over 700K shares with hardly any being sold.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News